⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7736989 | 0.81 | — | — | |
| SCHEMBL4620077 | 0.81 | — | — | |
| SCHEMBL545145 | 0.76 | TSHR (0.58) | — | |
| SCHEMBL28769934 | 0.76 | TSHR (0.31) | — | |
| SCHEMBL15170448 | 0.74 | TSHR (0.50) | — | |
| SCHEMBL3337174 | 0.72 | TSHR (0.31) | — | |
| SCHEMBL1045261 | 0.72 | — | — | |
| SCHEMBL8102031 | 0.69 | TSHR (0.30) | — | |
| SCHEMBL9259722 | 0.69 | — | — | |
| SCHEMBL21631359 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 362 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10202322-B2 | Resorcinol derivatives | SUTTER BAY HOSPITALS (US) | 2019-02-12 | — | — | US | claimed |
| US-20130209483-A1 | CANNABIDINOID DERIVATIVES | SUTTER WEST BAY HOSPITALS (US) | 2013-08-15 | — | — | US | claimed |
| US-20130087745-A1 | SOLUBLE PRECURSORS AND SOLUTION-BASED PROCESSES FOR PHOTOVOLTAICS | PRECURSOR ENERGETICS, INC. (US) | 2013-04-11 | — | — | US | claimed |
| EP-1633693-A1 | IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2006-03-15 | — | — | EP | claimed |
| WO-2004108653-A1 | IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2004-12-16 | — | — | WO | claimed |
| US-20240174947-A1 | SURFACTANT COMPOSITIONS | LANKEM LTD. (GB) | 2024-05-30 | — | — | US | disclosed |
| EP-4373529-A1 | FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF | 3B Pharmaceuticals GmbH (DE) | 2024-05-29 | — | — | EP | disclosed |
| US-20240115745-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2024-04-11 | — | — | US | disclosed |
| CN-113164361-B | Personal care compositions | 高露洁-棕榄公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-117769443-A | Fibroblast activation protein inhibitor and use thereof | 3B制药有限公司 | 2024-03-26 | — | — | CN | disclosed |
| WO-2024052431-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024043246-A1 | ANION EXCHANGE-TYPE POLYMER ELECTROLYTE MEMBRANE, WATER ELECTROLYSIS DEVICE, CARBON DIOXIDE ELECTROLYSIS DEVICE, FUEL CELL, AND PRODUCTION METHOD FOR ANION EXCHANGE-TYPE POLYMER ELECTROLYTE MEMBRANE | 三井化学株式会社 | 2024-02-29 | — | — | WO | disclosed |
| EP-0818512-A1 | Quinoline derivative and use of same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1998-01-14 | — | — | EP | disclosed |
| US-4206076-A | STABILIZERS AGAINST HEAT, LIGHT, OR OXYGEN | SANDOZ LTD. (CH) | 1980-06-03 | — | — | US | disclosed |
| US-4162351-A | Metal-halogen cell operation with storage of halogen via organic complexation external to the electrochemical cell | ELECTRIC POWER RESEARCH INSTITUTE, INC. (US) | 1979-07-24 | — | — | US | disclosed |
| US-4107138-A | Phosphonous and thiophosphonous acid ethers as stabilizers for organic materials | SANDOZ LTD. (CH) | 1978-08-15 | — | — | US | disclosed |
| US-4075230-A | Preparation of optically active trans-hexahydrodibenzopyranones | ELI LILLY AND COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
| US-3987097-A | INCREASING AFFINITY FOR ANIONIC DYES | SANDOZ LTD. (CH) | 1976-10-19 | — | — | US | disclosed |
| US-3948946-A | Cyclic acetals and mercaptals | SANDOZ LTD., (SANDOZ AG) (CH) | 1976-04-06 | — | — | US | disclosed |
| US-3936479-A | 2-BENZAMIDO-BENZOPHENONES, UV STABILIZERS, PLASTICS | SANDOZ LTD., (SANDOZ AG) (CH) | 1976-02-03 | — | — | US | disclosed |